NuPotential

NuPotential produces cell lines suitable for re-differentiation into multiple lineages and somatic cell nuclear transfers.

NuPotential, Inc. produces dedifferentiated cell lines suitable for re-differentiation into multiple lineages and somatic cell nuclear transfer. Its cells are used in therapies that reverse the debilitating effects of diabetes, stroke, heart disease, Alzheimer's disease, Parkinson's disease, and other afflictions, as well as in drug discovery tool applications. The company was founded in 2004 and is based in Baton Rouge, Louisiana.